Upadacitinib for Refractory Behcet's Syndrome: A Multi-center, Prospective, Open-label, Pilot Study

被引：0
|
作者：
Xia, Weiyi [1 ]
Li, Jiachen [1 ]
Liu, Tian [1 ]
Li, Yuhui [2 ]
机构：
[1] Peking Univ, Peoples Hosp, Beijing, Peoples R China
[2] Peking Univ, Beijing, Peoples R China
来源：
ARTHRITIS & RHEUMATOLOGY | 2024年 / 76卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2515
引用
收藏
页码：5121 / 5122
页数：2
相关论文
共 50 条
  • [21] A pilot study of tofacitinib for refractory Behcet's syndrome
    Liu, Jinjing
    Hou, Yunxia
    Sun, Luxi
    Li, Chaoran
    Li, Lu
    Zhao, Yan
    Zeng, Xiaofeng
    Zhang, Fengchun
    Zheng, Wenjie
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (11) : 1517 - +
  • [22] Comparison of aripiprazole versus bupropion augmentation for treatment of older patients with MDD: a randomized prospective open-label multi-center study
    Kim, H. G.
    Lee, K. H.
    Park, Y. W.
    Lee, J. H.
    Koo, B. H.
    Lee, S. J.
    Sung, H. M.
    Cheon, E. J.
    EUROPEAN NEUROPSYCHOPHARMACOLOGY, 2015, 25 : S437 - S438
  • [23] Tacrolimus for Children with Refractory Nephrotic Syndrome: A 1 year Prospective, Multicenter, Open-Label Study
    Park, Hye Won
    Kang, Hee Gyung
    Yang, Eun Mi
    Cheong, Hae Il
    Choi, Yong
    Ha, Il Soo
    PEDIATRIC NEPHROLOGY, 2013, 28 (08) : 1605 - 1605
  • [24] Efficacy results of pimavanserin from a multi-center, open-label extension study in Parkinson's disease psychosis patients
    Isaacson, Stuart H.
    Ballard, Clive G.
    Kreitzman, David L.
    Coate, Bruce
    Norton, James C.
    Fernandez, Hubert H.
    Ilic, Tihomir V.
    Azulay, Jean-Philippe
    Ferreira, Joaquim J.
    Abler, Victor
    Stankovic, Srdjan
    PARKINSONISM & RELATED DISORDERS, 2021, 87 : 25 - 31
  • [25] Open-label pilot study of ziprasidone for refractory generalized anxiety disorder
    Snyderman, SH
    Rynn, MA
    Rickels, K
    JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2005, 25 (05) : 497 - 499
  • [26] Open-label pilot study of tofacitinib 2% for the treatment of refractory vitiligo
    Mobasher, P.
    Guerra, R.
    Li, S. J.
    Frangos, J.
    Ganesan, A. K.
    Huang, V.
    BRITISH JOURNAL OF DERMATOLOGY, 2020, 182 (04) : 1047 - 1049
  • [27] Open-label intramuscular droperidol for the treatment of refractory headache: A pilot study
    Mendizabal, JE
    Watts, JM
    Riaz, S
    Rothrock, JF
    HEADACHE QUARTERLY-CURRENT TREATMENT AND RESEARCH, 1999, 10 (01): : 55 - 57
  • [28] Study of Tofacitinib in Refractory Dermatomyositis: An Open-Label Pilot Study of Ten Patients
    Paik, Julie J.
    Casciola-Rosen, Livia
    Shin, Joseph Yusup
    Albayda, Jemima
    Tiniakou, Eleni
    Leung, Doris G.
    Gutierrez-Alamillo, Laura
    Perin, Jamie
    Florea, Liliana
    Antonescu, Corina
    Leung, Sherry G.
    Purwin, Grazyna
    Koenig, Andrew
    Christopher-Stine, Lisa
    ARTHRITIS & RHEUMATOLOGY, 2021, 73 (05) : 875 - 884
  • [29] Photodynamic Therapy in Refractory Mycosis Fungoides: A Prospective, Open-Label Study
    Brumfiel, Caitlin M.
    Severson, Kevin J.
    Patel, Meera H.
    Cumsky, Helen J. L.
    Ginos, Brenda F.
    Kosiorek, Heidi E.
    Janeczek, Monica C.
    Besch-Stokes, Jake
    Rule, William
    DiCaudo, David
    Rosenthal, Allison C.
    Pittelkow, Mark R.
    Mangold, Aaron R.
    BLOOD, 2020, 136
  • [30] The efficacy and safety of aripiprazole combination with divalproex in patients with acute manic and mixed episode: A multi-center, prospective, open-label study (The SMART study)
    Bahk, W. -M.
    Woo, Y. S.
    Chung, M. Y.
    Kim, D. -H.
    Yoon, B. -H.
    Lee, J. H.
    Ahn, Y. M.
    Chung, S. -K.
    Kim, J. -G.
    Lee, K. H.
    Paik, K. -C.
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2010, 13 : 123 - 123
12345